Cardiovascular Complications of Pregnancy-Associated COVID-19 Infections
- PMID: 35967591
- PMCID: PMC9364954
- DOI: 10.1016/j.jacadv.2022.100057
Cardiovascular Complications of Pregnancy-Associated COVID-19 Infections
Abstract
Cardiovascular complications are frequently present in coronavirus-2019 (COVID-19) infection. These include microvascular and macrovascular thrombotic complications such as arterial and venous thromboembolism, myocardial injury or inflammation resulting in infarction, heart failure, and arrhythmias. Data suggest increased risk of adverse outcomes in pregnant compared with nonpregnant women of reproductive age with COVID-19 infection, including need for intensive care unit admission, mechanical ventilation, and extracorporeal membrane oxygenation utilization. Current statements addressing COVID-19-associated cardiac complications do not include pregnancy complications that may mimic COVID-19 complications such as peripartum cardiomyopathy, spontaneous coronary artery dissection, and preeclampsia. Unique to pregnancy, COVID-19 complications can result in preterm delivery and modify management of the pregnancy. Moreover, pregnancy has often been an exclusion criterion for enrollment in research studies. In this review, we summarize what is known about pregnancy-associated COVID-19 cardiovascular complications.
Keywords: CDC, Centers for Disease Control; COVID-19, coronavirus-2019; ECG, electrocardiogram; ECMO, extracorporeal membrane oxygenation; LV, left ventricular; MI, myocardial injury; PASC, postacute sequelae of SARS-CoV-2 infection; PPCM, peripartum cardiomyopathy; SCAD, spontaneous coronary artery dissection; Tn, cardiac troponin; arrhythmias; cardio-obstetrics; peripartum cardiomyopathy; preeclampsia; thromboembolic disease; vaccine induced thrombocytopenia.
© 2022 The Authors.
Conflict of interest statement
Dr Quesada has received external funding of 10.13039/100000002NIH, United States K23HL151867 award for investigation on hypertensive disorders of pregnancy. Drs Malhamé and Gibson McDonald hold Fonds de Recherche du Quebec-Santé (FRQS), Canada Career awards. Dr Gibson McDonald is a site investigator and member of steering committee for the ATTACC study. The sponsors for the ATTACC study had no role in interpretation of data for this study. Dr Briller is on the steering committee and a site investigator for the REBIRTH trial. All other authors have reported they have no relationships relevant to the content of this paper to disclose.
Figures




References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous